Nobel Prize Recognizes Pioneering Body's Defenses Discoveries

The prestigious award in Physiology or Medicine has been awarded for transformative findings that clarify how the immune system attacks harmful infections while sparing the body's own cells.

Three esteemed scientists—from Japan Prof. Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—share this accolade.

Their research uncovered unique "sentinels" within the defense system that remove malfunctioning defense cells that could harming the organism.

These findings are now paving the way for new therapies for immune disorders and cancer.

These laureates will share a monetary award valued at 11m SEK.

Crucial Findings

"The work has been essential for comprehending how the immune system operates and why we do not all develop serious autoimmune diseases," stated the head of the award panel.

The trio's studies explain a core mystery: In what way does the immune system protect us from countless invaders while keeping our healthy cells intact?

The body's protection system employs white blood cells that search for signs of infection, including pathogens and germs it has never encountered.

Such defenders employ detectors—called recognition units—that are generated randomly in a vast number of variations.

This gives the defense network the capacity to combat a broad range of threats, but the unpredictability of the mechanism inevitably produces white blood cells that can target the host.

Protectors of the Immune System

Scientists earlier understood that a portion of these harmful defense cells were destroyed in the thymus—where white blood cells mature.

The latest award recognizes the discovery of T-reg cells—known as the immune system's "security guards"—which travel through the system to disarm any immune cells that attack the body's own tissues.

We know that this process malfunctions in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and RA.

A prize committee stated, "The findings have established a new field of research and spurred the development of innovative therapies, for instance for cancer and immune disorders."

In malignancies, regulatory T-cells prevent the system from fighting the growth, so studies are aimed at lowering their numbers.

For self-attack disorders, experiments are exploring boosting regulatory T-cells so the organism is no longer under attack. A similar method could also be useful in reducing the risks of organ transplant rejection.

Pioneering Experiments

Professor Shimon Sakaguchi, of a Japanese institution, conducted experiments on rodents that had their immune gland removed, leading to self-attack conditions.

He showed that injecting immune cells from other mice could stop the disease—suggesting there was a mechanism for blocking immune cells from harming the body.

Mary Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an inherited autoimmune disease in rodents and people that led to the identification of a genetic factor vital for how regulatory T-cells operate.

"The groundbreaking research has revealed how the immune system is controlled by T-reg cells, stopping it from mistakenly targeting the healthy cells," commented a prominent biological science specialist.

"The research is a remarkable example of how basic biological research can have broad implications for public health."